Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
The Oncologist|March 19, 2017
Academic Cancer Center Phase I Program DevelopmentArthur E Frankel, Keith T Flaherty, George J Weiner, et al.Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic AdenocarcinomaPhilip A Philip, Ibrahim Azar, Joanne Xiu, et al.JAMA Oncology|December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET StudyEli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.JCO Precision Oncology|February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR AlterationsDavid M Hyman, Ben Tran, Luis Paz-Ares, et al.The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.Breast Cancer Research and Treatment|December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancerCynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.Science Advances|June 25, 2020
The clonal evolution of metastatic colorectal cancerHa X Dang, Bradley A Krasnick, Brian S White, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Gastric cancer, version 2.2013: featured updates to the NCCN GuidelinesJaffer A Ajani, David J Bentrem, Stephen Besh, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Esophageal and esophagogastric junction cancers, version 1.2015Jaffer A Ajani, Thomas A D'Amico, Khaldoun Almhanna, et al.Pageof 10